European review for medical and pharmacological sciences

255 papers and 3.0k indexed citations i.

About

The 255 papers published in European review for medical and pharmacological sciences in the last decades have received a total of 3.0k indexed citations. Papers published in European review for medical and pharmacological sciences usually cover Molecular Biology (113 papers), Cancer Research (107 papers) and Pulmonary and Respiratory Medicine (26 papers) specifically the topics of Cancer-related molecular mechanisms research (82 papers), Circular RNAs in diseases (64 papers) and MicroRNA in disease regulation (39 papers). The most active scholars publishing in European review for medical and pharmacological sciences are Wang Ll, Liu L, Vittorio Unfer, Xiaobo Zhang, Li X, Mohammad Ali Ebrahimzadeh, Xiyong Liu, Sohair R. Fahmy, S M Nabavi and Jing Ma.

In The Last Decade

Fields of papers published in European review for medical and pharmacological sciences

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in European review for medical and pharmacological sciences. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in European review for medical and pharmacological sciences.

Countries where authors publish in European review for medical and pharmacological sciences

Since Specialization
Citations

This map shows the geographic impact of research published in European review for medical and pharmacological sciences. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in European review for medical and pharmacological sciences with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites European review for medical and pharmacological sciences more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2025